2,685 results on '"POSTURAL orthostatic tachycardia syndrome"'
Search Results
2. NC Testing in LC & POTS
3. Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS (POTS)
4. Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Syndrome (POTS)
5. CAlgary SAlt for POTS (CASA-POTS)
6. Low Dose Naltrexone Use in Patients With POTS
7. Compression Garments in the Community With POTS (COM-COM-POTS)
8. Hypercapnia and Orthostatic Tolerance in Postural Orthostatic Tachycardia Syndrome
9. Crossover Study of Propranolol vs Ivabradine in POTS
10. POTS Adrenergic Ab (CIHR Aims #1&2)
11. Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS (POTS)
12. Phenotyping Mitochondrial and Immune Dysfunction in POTS With Targeted Clinical Intervention.
13. fMRI in Postural Tachycardia Syndrome (POTS)
14. Phenotyping of Postural Orthostatic Tachycardia Syndrome (POTS)
15. Aldosterone & Sodium Regulation in Postural Tachycardia Syndrome - Screening
16. The Effect of Physical Activity on Postural Orthostatic Tachycardia Syndrome (POTS)
17. The Long COVID-19 Wearable Device Study
18. Splanchnic Venous Capacitance in Postural Tachycardia Syndrome
19. The Impact of Improved Vagal Function on Periaqueductal Gray Connectivity
20. IVIG (Gamunex-C) Treatment Study for POTS Subjects (iSTAND)
21. Vagal Stimulation in POTS
22. Autoimmune Basis for Postural Tachycardia Syndrome
23. VNS for Long-COVID-19
24. Long COVID Immune Profiling
25. A Study of Pyridostigmine in Postural Tachycardia Syndrome
26. Autoimmune Basis for Postural Tachycardia Syndrome
27. A mHealth System for Patients With POTS
28. Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome
29. A Shared Medical Appointment Intervention for Quality of Life Improvement in POTS
30. Physical Training in Patients With POTS After Covid-19 (POTS-ReCOV)
31. Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life
32. Using Mirabegron to Increase BP in Patients With POTS (RAISE BP)
33. Modafinil and Cognitive Function in POTS
34. Autonomic Determinants of POTS - Pilot 2
35. Autonomic Determinants of POTS - Pilot1
36. Transdermal Vagal Stimulation for POTS
37. Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?
38. Acceleration index predicts efficacy of orthostatic training on postural orthostatic tachycardia syndrome in children.
39. Advanced clinical reasoning in the diagnosis of spinal cerebrospinal fluid leaks.
40. Preliminary study on the efficacy of ryokeijutsukanto in the management of orthostatic dysregulation: A prospective observational study.
41. Postural orthostatic tachycardia syndrome in a Thai male patient.
42. The Suggested Relationships Between Common GI Symptoms and Joint Hypermobility, POTS, and MCAS.
43. Navigating Complexity in Postural Orthostatic Tachycardia Syndrome.
44. Postural Orthostatic Tachycardia Syndrome Associated with COVID-19: A Narrative Review.
45. Clinical and endocrine features of orthostatic intolerance detected in patients with long COVID.
46. Stress-Related Chronic Fatigue Syndrome: A Case Report with a Positive Response to Alpha-Methyl-P-Tyrosine (AMPT) Treatment.
47. Palpitations in athletes: diagnosis, workup and treatment.
48. One or many labels? a longitudinal qualitative study of patients' journey to diagnosis at a specialist NHS Postural Tachycardia Syndrome (PoTS) clinic.
49. Deep abdominal breathing reduces heart rate and symptoms during orthostatic challenge in patients with postural orthostatic tachycardia syndrome.
50. Factors associated with initiation of pharmacological therapy and treatment changes in postural orthostatic tachycardia syndrome.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.